NEUROBO ANNOUNCES CLOSING OF $32.3 MILLION UNDERWRITTEN PUBLIC OFFERING INCLUDING FULL EXERCISE OF OVERALLOTMENT OPTION AND CONCURRENT PRIVATE PLACEMENT Nov 8, 2022 04:05PM
NeuroBo Pharmaceuticals (NRBO) Announces Pricing Of $30 Million Underwritten Public Offering And Concurrent Private Placement Nov 4, 2022 09:16AM
NEUROBO ANNOUNCES PRICING OF $30 MILLION UNDERWRITTEN PUBLIC OFFERING AND CONCURRENT PRIVATE PLACEMENT Nov 4, 2022 09:15AM
NeuroBo Pharmaceuticals (NRBO) Reports License Agreement with Dong-A Sep 15, 2022 07:52AM